Upload
ronnie-inso
View
224
Download
0
Embed Size (px)
Citation preview
8/4/2019 SCI Case Presentation Final
1/44
SPINAL CORD INJURY
A Case Presentation
As Partial Fulfillment for the subject NCM 102E, Care of Mother, Child, Family and group at risk with Problems
STI College Baguio Branch
8/4/2019 SCI Case Presentation Final
2/44
I. PATIENTS PROFILE A. BIOGRAPHIC DATA
Name: Patient XAge: 41 Years oldAddress: Supang, Sabangan, MountainProvinceCivil Status: MarriedSex: MaleOccupation: LaborerReligious Preference/Affiliation: AnglicanHealthcare Finances: None
Chief Complain: Inability to move his body
B. HISTORY OF PRESENT ILLNESSThe present condition started 17 hours prior to admission when patient was riding
on his tricycle going home when he lost control and fell to a clift in Bauko, MountainProvince. He was brought to Abatan Bauko General Hospital where first aid andintubation was done. X-ray was also done. He was then referred to Baguio GeneralHospital Medical Center for further evaluation and suggestion.
C. PAST MEDICAL HISTORYPatient was hospitalized in Abatan Bauko General Hospital for fracture on his left
Tibia last August 1993. No known allergies as to environmental, food and drugs asinformed by patients sister .
D.
FAMILY HISTORY OF ILLNESSNo known hereditary familial disease running in the family. There are no historiesof Hypertension, CVA/Stroke, Heart problems, Asthma, Mental Illness, KidneyProblems, Cancer, and Epilepsy from both parents. Neither are there known such
8/4/2019 SCI Case Presentation Final
3/44
Social Development StatusThe patient is a 41 year old male and is married. His sister says that he
prefers going out to look for a laboring job or sometimes farming job ratherthan going out with his friends.
B. MENTAL AND EMOTIONAL STATUS Mental Status
The patient is awake. He was not able to respond to touch and painfulstimuli as to anatomical structures below the level of spinal cord affectationbut was able to respond it as to anatomical structures above the level of spinalcord affectation, verbal stimuli, noise and light. He is oriented to place andpersons. He has the ability to comprehend and give signals as necessary. Hehas a Glasgow Coma Scale of 11.
Emotional StatusHis mood and emotional response are observable through his facial
expression. He is able to react with stressful situations which were expressedthrough changes in facial expression and crying. No stimulant or depressantwas given to alter his emotional response.
C. ENVIRONMENTAL STATUS Safety factors
The patient was placed in a position that his head was near the pathway of the ward which could pose as potential hazard since people (watcher, visitoror other healthcare members) might accidentally collide or sideswipe the
weights of the halo traction of the patient. There are no side rails present in the patients bed and the space is not enough for the personal and medical thingsneeded by the patient.
8/4/2019 SCI Case Presentation Final
4/44
D. SENSORY STATUS
EyeHis palpebral conjunctiva is pale and his bulbar conjunctiva is white and
clear. Both of his pupils constrict in response to light. His eyes aresymmetrical in shape.
Auditory StatusHe is able to distinguish voice. The external ears are equally patent. The
ears are symmetrical. He has poor ear hygiene as evidenced by the presence of earwax in the ear canal.
NoseThe nose is symmetrical. There is a presence of Nasogastric Tube.
Cranial Nerve assessment:Cranial nerve Assessment outcome
CN I(Olfactory) Not TestedCN II (Optic) IntactCN V (Trigeminal) IntactCN VII (Facial) IntactCN VIII (Acoustic) IntactCN IX (Glossopharyngeal) Not TestedCN X (Vagus) Intact
Tactile StatusThe patient was not able to feel discriminative and non-discriminative
8/4/2019 SCI Case Presentation Final
5/44
8/4/2019 SCI Case Presentation Final
6/44
Patellar 0 0Ankle Reflex 0 0
E. MOTOR STATUS Medical restrictions on Activity
Patient is bedbound restricted by the presence of Halo traction and inability tomove.
Musculoskeletal Range of Motion
Full range of motion of both the upper and lower extremities wasachieved through passive movement with firm end feel. Range of motion for the cervical and thoracic spine was not assessed due tomedical restriction (Presence of Halo Brace).
Muscle Strength Upper ExtremitiesHe has a Grade of 0 muscle strength for both the upper extremities.
Muscle Strength Lower ExtremitiesHe has a Grade of 0 muscle strength for both the lower extremities.
CerebellarUnable to assess since patients muscle for both upper and lower extremities are flaccid thereby restricting the assessment for thecerebellum function.
Cranial nerve assessmentCranial Nerve Assessment Outcome
CN III (Oculomotor) Intact
CN IV (Trochlear) IntactCN V (Trigeminal) IntactCN VI (Abducens) IntactCN VII (F i l) I t t
8/4/2019 SCI Case Presentation Final
7/44
MobilityPatient is totally dependent with functional level classification of 4. He is
non-ambulatory and needs full assistance in activities of daily living. He isunable to do active bed mobility. Passive bed mobility is minimized due to therestriction of the halo traction.
F. NUTRITIONAL STATUS Dietary Habits
Patient prefers to eat vegetables and seldom eats fish and pork due tofinancial status.
Adequacy of DietPatient uses NGT and is given osteorized food three times a day
(breakfast, lunch and dinner). Signs of diet inadequacy cannot be assessedfully since most of the signs seen are also a typical signs for denervation andits complications. The patients sister verbalized that there is no change inphysique of the patient.
Non-oral means of feedingThe patient uses NGT.
G. ELIMINATION STATUS Normal Patterns
The patients normal defecation is daily or once a day with normal amountand consistency as verbalized by her sister. He also urinates regularly and
there were no known reports of hematuria, past stones Aids to Elimination
Patient is immobile and consumes less amount of water which is a
8/4/2019 SCI Case Presentation Final
8/44
pH 6.0 4.5-8.0 NormalSpecific
Gravity:
1.030 1.015-1.025 High; Increased concentration of dissolved
solutes probably due to large amount of medications given. Indicative of early signsof dehydration
Sugar: Negative Negative NormalProtein: Negative -
TraceNegative Normal
RBC: Toonumerous tocount
Negative orrare
High; Indicative of Urinary tract injury
Method: Immunochromatography*** January 30, 2011; 12:48 A.M.
H. FLUID AND ELECTROLYTE STATUS
Specific gravity is 1.030 (taken last January 30, 2011) which is indicative of earlysigns of dehydration, PNSS IL X 8 was infused. Patient has decreased input of water.An IFC is connected with a range from 850 1,100 cc output per day. Currently,PNSS 1L X 16 hours with side drip of Dopamine x 5ugtts/min is infused.
I. CIRCULATORY STATUS
He has good skin turgor and a capillary refill of
8/4/2019 SCI Case Presentation Final
9/44
RDW CV 12.9% 11.5 14.5 NormalRDW SD 41.4 fL 35.0 56. 0 Normal
PLT 208 x 10^9/L 150 450 NormalMPV 10.9 fT 7. 0 11.0 NormalPDIV 15.1 15.0 17.0 NormalPCT 0.226% 0.108 0.282 Normal*** January 29, 2011
Hematology Result form
Parameter Result ReferenceRange
Interpretation
WBC 11.8 x 10^9/L 5.0 10.0 High; Indicative of infectionLYMPH 1.5 x 10^9/L 0.8 4.0 Normal MIDH 0.4 x 10^9/L 0.1 0.9 Normal GRANH 9.9 x 10^9/L 2.0 7.0 High; Indicative of infection
LYMPH% 12.9% 20.0 45.0 Low; Indicative of low immune systemMID% 3.8% 3.0 9.0 NormalGRAN% 83.3% 40.0 75.0 High; Indicative of infectionHGB 130 g/L 140 180 Low; Indicative of defects in the balance of
red blood cells in the blood RBC 4.50 x 10^12/L 4.00 5.50 NormalHCT 37.4% 42. 6 54.0 Low; Indicative of nutritional deficiencies of
iron, folate, vitamin B12, and vitamin B6 MCV 83.3 fL 82.0 95.0 NormalMCH 28.8pg 27.6 31.0 NormalMCHC 374 g/L 326 360 High; Indicative of vitamin B12 deficiency
8/4/2019 SCI Case Presentation Final
10/44
RANGELDL 1.1 mmoL/L 0 - 5.2 Normal
Sodium 141.1 mmoL/L 136 - 145 NormalPotassium 4.0 mmoL/L .35 5.1 NormalChloride 168.7 mmoL/L 98 107 High; Indicative of respiratory
alkalosisTriglycerides 0.59 mmoL/L 0 1.69 NormalBlood UreaNitrogen
13.99 mmoL/L 2.56 6.49 High; Patient is in statecharacterized by decreasedeffective circulating blood volumewith decreased renalperfusion; Patient is possibly in astate of shock
Cholesterol 2.69 mmoL/L 0 5.2 Normal;Glucose 5.41 mmoL/L 3.85 6.05 Normal;Creatinine 136.99 ummoL/L 71 115.00M High; Indicative of renal failureHDL
Cholesterol
1.33 umMmoL/L 53 88.4F
1.04 1.56
Normal
Conventional UnitsTEST NAME RESULT UNIT REFERENCE
RANGEInterpretation
LDL 42.31 mg/dl 0 200 NormalSodium 141.10 mg/dl 136 145 NormalPotassium 4.00 mg/dl 3.5 5.1 NormalChloride 108.70 mg/dl 98 107 High; Indicative of respiratory
alkalosisTriglycerides 52.44 mg/dl 0 150 NormalBlood UreaNit
39.19 mg/dl 7.0 18.0 High; Patient is in stateh t i d b d d
8/4/2019 SCI Case Presentation Final
11/44
Arterial Blood GasResult Normal values Interpretation
pH 7.481 7.35 7.45 Alkalinic; Indicative of possible hyperventilationor shock
pCO2 17.4 mmhg 35 45 mmhg Low; indicative of hyperventilation or hypoxiapO2 80.4 mmhg 80 100 mmhg NormalHCO3 12.7 mmol/L 22 26 mEq/L Low; indicative of respiratory alkalosis (which
can be caused by hyperventilation),metabolic acidosis, shock, starvation, and orkidney failure.
SO2 96.5 % 95 98 % NormalBE - 7.7 mmol/L -2 - +2
-5 - +3Indicates a base deficit in the blood equivalent toan acid excess
F1O2 60 % 60% or less NormalTHb _____g/dl No data / measurement furnished in the
laboratory resultHct 37.4 % 39 54% Low; indicative of loss of blood
Na 136.7 mmol/L 135-145 mmol/L NormalK 2.80 mmol/L 3.4-4.6 mmol/L LowICa .522 mmol/L*** January 30, 2011
J. RESPIRATORY STATUS Inspection
Color of the thorax is lighter as compared to the skin color of the face andextremities. He has no visible deformity over the anterior aspect of the thoraxarea.
8/4/2019 SCI Case Presentation Final
12/44
Result Heavy Growth of Klebsiella Pneumoniae
Amikacin SAmpicillin RAmoxicillin / Clavulanic Acid
S
Ampicillin / Sulbactan
I
Aztreonam SCefepime SCefexime SCefatoxime ICefuroxime RCefoxitin RCeftrioxone S
Cytazidine IChloramphenicol RCiprofloxacin SCotrimoxazole RGentamycin SImepenem SErtapenem SMeropenem SPipracillin RPiperocillin /
TazobactamI
8/4/2019 SCI Case Presentation Final
13/44
K. TEMPERATURE STATUSHis temperature ranged from 36.3 to 36.6 degrees Celsius on his first week with
elevation ranged from 37.7 to 38 degrees Celsius noted during the second week takenin axillary area. He uses a blanket as a usual measure for temperature comfort.
L. INTEGUMENTARY STATUSHis skin is dark brown, dry and flaky. Nail beds are light brown to reddish with
nails not trimmed. Skin is warm to touch. With bruise on medial aspect of the leftelbow, lateral aspect of the left knee, anterior proximal third of the left leg, antero-medial side of the right distal leg and hematoma on postero-lateral side of leftshoulder with approximately 1 inch in diameter, lateral side of the left hip withapproximately half inch in diameter. With clean and dry pinholes in the anterior andlateral portions of the scalp due to insertion of the pins of the halo traction. Palpablelymph node enlargement was noted on both sides of the neck. With Braden Scale asfollows:
Date Total Score InterpretationFebruary 3, 2011 10 High Risk for Pressure SoreFebruary 4, 2011 10 High Risk for Pressure Sore February 11, 2011 10 High Risk for Pressure Sore
8/4/2019 SCI Case Presentation Final
14/44
III. PATHOPHYSIOLOGY
Spinal Cord Injury: PathophysiologyComplete
Risk for infection(e.g Pneumonia)
Spinal Shock:Loss of Somatic Sensation;Loss of visceral Sensation;
loss of motor Function;Loss of muscle tone; loss
of reflex activity
Ischemia from damage / Impingement on the spinalarteries
Compression/ directtrauma of the SpinalCord by the Bonefragments
Fracture of vertebraeand tear of ligaments onthe cervical vertebrae(C3 C4); dislocation of facet oints
Motor Vehicle Accident
IneffectiveBreathing Pattern
Microscopic hemorrhagesappear in the central graymatter & pia-arachnoidcausing reduced vascularperfusion & development of ischemic areas
8/4/2019 SCI Case Presentation Final
15/44
Stage of Flexor Muscle SpasmIncreasing tone in flexor muscleStronger flexor response to nociceptivewhich progressively involve more proximal
rou
Stage of Predominant Extensor Spasticity
Stage of alternate Flexor and ExtensorSpasticity
Both flexor and extensor spasms occur,patient can momentarily support his weightin standin osition
A
8/4/2019 SCI Case Presentation Final
16/44
IV. LIST OF PROBLEMS
1. Ineffective airway clearance related to neuromuscular dysfunction and infection secondaryto C 3 C4 jump facet.2. Ineffective breathing pattern related to musculoskeletal impairment secondary to C 3 C4
jump facet.3. Impaired mobility related to loss of muscle function as manifested by paralysis of both
upper and lower extremity secondary to C 3 C4 jump facet.4. Risk for impaired skin integrity related to physical immobility secondary to C 3 C4 jump
facet.
5. Risk for decrease cardiac output related to neurogenic shock secondary to C 3-C4 jump facet.
8/4/2019 SCI Case Presentation Final
17/44
17
V. NURSING CARE PLANProblem 1: Ineffective airway clearance
ASSESSMENT EXPLANATION OFTHE PROBLEM
OBJECTIVES INTERVENTION RATIONALE EVALUATION
S: Ado tirumrumuar ngaterkak ditoy kwa na(pointing to theBVM) as verbalized
by the patients sister
O: With
tracheostomyconnected toBVM with 8-9lpm oxygeninhalation
Alteredrespiratory depthand rate noted
Withtracheobronchialsecretions (dark yellow to lightgreen in color)
With oxygensaturation of 94to 97 %
With excessivesalivation
Impairedcoughing reflexnoted
Presence of
Trauma to the C3 C4Cervical spine
Injury to the spinal cord
Denervationand loss of function of respiratory
muscles
Intubation
Invasionand
colonizationof
microorganismin the
respiratorytract
Infection
Inflammatory
STO:Maintain oxygensaturation not togo below normalrange.
LTO:Maintain optimaloxygen saturationwhile patient is inthe hospitalthroughappropriatenursingintervention
Diagnostic: Monitoredoxygensaturation asappropriate
Assessed skincolor andtemperature
Monitoredairwayresistance
IncreasingPaCo2 anddecreasingPaO2 are signsof respiratoryfailure. As thepatients beginto fail therespiratory ratedecreases andPaCO2 begin toincrease.
To assesscyanosis whichcan occur whenat least 5 g of hemoglobin isdesaturated orcool pale skinwhich canoccursecondary to acompensatoryresponse tohypoxemia.
Increase of resistancesignals
Goals Met.Maintainedoxygen saturation
Goal Partiallymet:Continue nursinginterventions asneeded
O v e r r o
d u c t
i o n o
f s a l
i v a
A f f e c
t a t i o n o f
t h e
A N S
8/4/2019 SCI Case Presentation Final
18/44
18
KleibsiellaPneumoniae inbacteriologyresult
No cyanosisnoted with skinwarm to touch
Sputumyellowish togreenish
Nursing Diagnosis:Ineffective airwayclearance related toneuromusculardysfunction andinfection secondaryto C 3 C4 jumpfacet.
process
Fever,sputum
production
Ineffectiveairway
clearance
Observedsputum colorand amount
Checked forthe position of the patient
Therapeutic: Suctioningdone as needed
Provided oralcare
accumulationof secretions of fluids
Signs of infection couldalso be seen incolor
Improperpositioningmay also causeabdominalcontents frompushingupwards thatmay causeairway
To removesecretions
impediment
Providing oralcare maydecrease
colonizationand increase of bacteria
For monitoringrespiratoryinfection thatmay increase
8/4/2019 SCI Case Presentation Final
19/44
19
Increased fluidintake
Collaborative: Collected andsent sputumspecimen forculture andsensitivitytesting, asappropriate
Administeredmedication (N-acetylcysteine,terbutiline) asordered notingeffectivenessand side effects
Educative: Emphasizedimportance of hand washingtechnique
sputumproduction.
Helps inliquefying andlooseningsecretions
To promoteclearance of airwaysecretions andbronchodilationdecreasesairwayresistance
This willdecrease if noteliminate thetransmission of microorganismto therespiratory tractwhileperforming the
bag valve mask ventilation.
Certainallergens canincrease mucusproductions.
8/4/2019 SCI Case Presentation Final
20/44
20
Explainedaboutenvironmentalfactors that canprecipitaterespiratoryproblems
8/4/2019 SCI Case Presentation Final
21/44
21
Problem 2: Ineffective Breathing Pattern
ASSESSMENT EXPLANATIONOF THE
PROBLEM
OBJECTIVES INTERVENTION RATIONALE EVALUATION
O: With
tracheostomyconnected toBVM with 8-9lpm oxygeninhalation
Paralyzedmuscles forbreathing noted
Alteredrespiratory depthand rate noted
With alteredinspiratory andexpiratorypressure.
Altered chestexcursion
Withtracheobronchialsecretions
With oxygensaturation of 94to 97 %
Improper bodypositioning noted
Trauma to the C3 C4 Cervical spine
Injury to the spinalcord
Loss of function of phrenic nerve and
other nervessupplying the
respiratoryaccessory muscles
Denervation of diaphragm and
accessory musclesof respiration
Paralyzeddiaphragm and
accessory musclesof respiration
Ineffectivebreathing pattern
STO:
Within 1 hour of nursing interventionthe oxygen saturationwill increase from 94-97% to 96 100%
LTO:Maintain optimaloxygen saturationwhile patient is in thehospital throughappropriate nursingintervention
Diagnostic: Monitoredoxygen saturationas appropriate
Assessed skincolor andtemperature
Therapeutic:Independent:
Positioned thepatient withproper bodyalignment
Increasing PaCo2and decreasingPaO2 are signs of respiratory failure.As the patientsbegin to fail therespiratory ratedecreases andPaCO2 begin toincrease.
To assess cyanosiswhich can occurwhen at least 5 g of hemoglobin isdesaturated or coolpale skin whichcan occursecondary to acompensatoryresponse to
hypoxemia.
for optimal chestexcursion or lungexpansion
Goals Met.Oxygen saturationincreased from 94-97% to 96 100%
Goal partially met:Continue nursinginterventions asneeded
8/4/2019 SCI Case Presentation Final
22/44
22
Nursing Diagnosis:Ineffective breathingpattern related toNeuromusculardysfunctionsecondary to C 3 C4
jump facet.
Demonstratedproper rate,rhythm and depthof ambubagging
Collaborative: Administeredmedicine(dopamine,Terbutaline) asneeded
Educative: Emphasizedimportance of properambubagging
Emphasized towatcher theimportance of proper bodyalignment / positioning of thepatient.
To educate thewatcher on properambubagging
DopamineReplaces the actionfor sympatheticnervous systemand terbutaline forbronchodilation
This preventsexacerbation of the
patients condition
To educate watcheron its advantageand disadvantage
8/4/2019 SCI Case Presentation Final
23/44
23
Problem 3: Impaired mobility
ASSESSMENT EXPLANATIONOF THE
PROBLEM
OBJECTIVES INTERVENTION RATIONALE EVALUATION
S: haan na ngamaikuti ti baggi naas verbalized by
patients sister
O: With muscle
grade of 0 onboth upper andlowerextremities
Inability toperform ActiveRange of motionnoted
With score of 4 totallydependent infunctionalactivities of
daily living
Impaired bedmobility noted
Nursing Diagnosis:Impaired mobilityrelated to loss of muscle function as
Trauma to the C3 C4 Cervical spine
Injury to the spinalcord
Loss of function of peripheral nerves
Denervation of upper extremity,
thoracic, abdominaland lower extremity
muscles
Impaired Mobility
STO:Within 3 hours of nursing interventionwatcher willverbalizeunderstanding onimportance of health teaching andwill be able todemonstrate properperformance of activities related topreventing thecomplications of immobility.
LTO:While patient is inthe hospital, he willbe free of complications of
immobility, throughappropriate nursinginterventions.
Diagnostic: Assessed for joint mobility / Range of motionand muscle tone
Assessedeliminationstatus
Assessed thewatchersknowledge of immobility anditscomplications
Therapeutic: Positioned thepatient withproper bodyalignmentthroughtrochanter rollsand pillows.Supported feet
Regularexaminations of the joint andmuscle tone willallow forprevention orearly recognitionand treatment forcontractures.
Immobilitypromotesconstipation
Inappropriateknowledge of the watcher willincrease the risksof complication
To preventsecondarymusculoskeletaldeformities thatmay occur
Goal met:Patient verbalizedunderstanding of thehealth teachings andwas able to properlydemonstrateactivities taught.
Goals Partially met:Continue nursinginterventions asneeded
8/4/2019 SCI Case Presentation Final
24/44
24
manifested byparalysis of bothupper and lowerextremity secondaryto C 3 C4 jumpfacet.
in dorsiflexedposition
Performedpassive range of motion exerciseson all joints of the extremitiesusing slow andsmoothmovements.
Repositionedperiodically
(every 2 hours)to changepressure sites
Elevated lowerextremities atregular intervals
Collaborative: Consulted withphysicaltherapist
To enhancecirculation,restore ormaintain muscletone and jointmobility andprevent disusecontractures anddelay muscleatrophy
Promotesperipheral
circulation andreduces pressure.
To prevent bloodpooling andvenous stasisand decrease risk of thrombus
formation
Helpful inplanning andimplementingindividualizedexercise
8/4/2019 SCI Case Presentation Final
25/44
25
Educative: Instructedwatcherregardinghazards of immobility
Emphasized towatcher theimportance of proper bodyalignment /
positioning of the patient.
Emphasizedimportance of passive range of motion exercises
program.
Informationpromotesawareness of thecomplications sothat watcher willbe able toidentify andreport signsimmediately.
To educatewatcher on itsadvantage anddisadvantage
To provideinformation onpreventingdelayingpossiblemusculoskeletalcomplications
8/4/2019 SCI Case Presentation Final
26/44
26
Problem 4: Risk for impaired skin integrity
ASSESSMENT EXPLANATIONOF THE
PROBLEM
OBJECTIVES INTERVENTION RATIONALE EVALUATION
O:
With bradenscore of 10(high risk forpressure sores)
Patient wearsdiaper
Uses flatsurfaced
mattress
With score of 4 totallydependent infunctionalactivities of daily living
Nursing Diagnosis:
Risk for impairedskin integrityrelated to physicalimmobilitysecondary to C 3 C4
jump facet.
Trauma to the C3 C4 Cervical spine
Injury to the spinalcord
Denervation of bothupper extremity,thoracic , back,abdominal, and
lower extremity
Prolongedimmobilization
Risk for skin
integrity
STO: After 1 hour of
nursingintervention thewatcher will beable to verbalizeunderstandingof the healthteaching
After 2 hours of nursing
intervention thewatcher will beable to performproperprocedures onpreventingpressure sores
LTO: While patient is
in the hospital,there will be aminimizedemergence of pressure sores,throughappropriatenursinginterventions
Diagnostic: Assessed abilityto move
Assessed generalcondition of skin,specifically overbonyprominences
Assessed foredema
Assessed forenvironmentalmoisture
Therapeutic: Performedpassive range of motion exercises
Immobility is thegreatest risk factor in skinbreakdown
Areas where skinis stretched tautlyover bonyprominences areat higher risk forbreakdown
because thepossibility of ischemia to skinis high.
Skin stretchedtautly overedematous tissueis at risk forimpairment
Moisture maycontribute to skinmaceration.
Promotesperipheralcirculation and
Goals met:Watcher verbalizedunderstanding of thehealth teaching andwas able to performproper procedureson preventingpressure sores
Goals Partially met:Continue nursing
interventions asneeded
8/4/2019 SCI Case Presentation Final
27/44
27
and cooperationof the watcher.
on all joints of the extremitiesusing slow andsmoothmovements.
Demonstratedand Cleaned,dried andmoisturized skin
Repositionedperiodically(every 2 hours)to changepressure sites
Educative: Teach the
watcher the
causes of pressure ulcerdevelopment:pressure on skin,especially overbonyprominencesShearing of friction against
reduces pressure.
These measuresreduce skinbreakdown fromprolongedimmobility
Because of sensorydisturbance thepatient will beunable to detect
painful pressure.Lift shits reduceshear forceswhich furthercontribute to skinbreak down
Thisinformationcan assist
the watcherin findingmethods toprevent skinbreakdown.
8/4/2019 SCI Case Presentation Final
28/44
28
skin.
. Teach the
watcher toinspect the skindaily
Skinbreakdownis anongoing,lifetimeconcern forthe patient.
8/4/2019 SCI Case Presentation Final
29/44
29
Problem 5: Risk for Decreased Cardiac outputASSESSMENT EXPLANATION OF THE
PROBLEMOBJECTIVES INTERVENTION RATIONALE EVALUATION
O: With blood
pressure of 100/60 mmhgand pulse rate of 51 56 beats perminute
Alert
Capillary refill of < 2 seconds
Nursing Diagnosis:Risk for decreasecardiac outputrelated to neurogenicshock secondary toC3-C4 jump facet.
Trauma to the C3 C4Cervical spine
Injury to thespinal cord
Neurogenic shock
Decreased Cardiac Output
STO:Within 8 hoursof nursingintervention
patients heartrate will increasefrom 51 56beats per minuteto 60 100 beats
LTO:During the stayin the hospital,
patients heartrate of 60-100beats per minuteand systolicblood pressuregreater than 90mm hg will bemaintainedthrough propernursing
intervention
Diagnostic: Assessed Heart
rate and BPclosely
Assessedperipheral pulses
and capillaryrefill.
Monitored intakeand output
Therapeutic: Avoided
elevating headof bed
Loss of sympatheticintervention resultsin bradycardia andvasodilation of vessels below theinjury resultingfrom an unopposedParasympatheticnervous system.
Peripheralvasodilation
decrease venousreturn, furtherdecreasing cardiacoutput and bloodpressure.
Changes in intakeand urine outputare an indicationsof fluid balance.
Because of sympatheticdisruption andresultant loss of vasoconstrictortone below theinjury, head
Goal met: patients heartrate increasedfrom 51 56beats per minuteto 65 70 beatsper minute
Goals Partiallymet:
Continue nursinginterventions asneeded
8/4/2019 SCI Case Presentation Final
30/44
30
Performedpassive range of motion exercises
on all joints of the extremitiesusing slow andsmoothmovements.
Collaborative: Administered
medicine asnecessary
Emphasizedimportance of passive range of motionexercises
elevation willresult in furtherdrop of BP.
Promotesperipheralcirculation
Dopamineincreases heart rateand blood pressure
To provideinformation aboutthe effects of PROME
8/4/2019 SCI Case Presentation Final
31/44
31
VI. DRUG STUDY.Tradename/Genericname
Classification/Indication Mechanism of action
Adverse effect/Contraindication Nursing Intervention
Ketorolac nonsteroidalantiinflammatory drugs(NSAIDs)
IndicationIt is for short-termmanagement of moderate to severepostoperative pain.
Short-term
management of
pain (up to 5
days)
Ophthalmic:
relief of ocular
itching due to
seasonal
conjunctivitis
and relief of
post-operativeinflammation
after cataract
surgery.
Inhibitsprostaglandinsynthesis by
decreasing theactivity of theenzyme, cyclo-oxygenase,which results indecreasedformation of prostaglandinprecursors
Percentage unknown: Renal impairment,wound bleeding (with I.M.), postoperativehematomas
1% to 10%:
Cardiovascular: Edema
CNS: Drowsiness, dizziness, headache, pain
Gastrointestinal: Nausea, dyspepsia, diarrhea,gastric ulcers, indigestion
Local: Pain at injection site
Miscellaneous: Diaphoresis (increased)
8/4/2019 SCI Case Presentation Final
32/44
32
ketorolac, aspirin, or other NSAIDs prophylaxis before major surgery suspected or confirmed
cerebrovascular bleeding, hemorrhagic diathesis
6 hrs to maintainserum levels andcontrol pain.
Tradename/Genericname
Classification/Indication Mechanism of action Adverseeffect/Contraindication
Nursing Interventions
Cefuroxime ANTIINFECTIVE;ANTIBIOTIC; SECOND-GENERATIONCEPHALOSPORIN
Treatment of infections causedby staphylococci,group Bstreptococci, H.influenzae (typeA and B), E. coli,Enterobacter ,Salmonella , andKlebsiella ;
treatment of susceptible
infections of the lower respiratory
tract
otitis media
urinary tract,
Inhibits bacterial cellwall synthesis bybinding to one or moreof the penicillin-binding proteins(PBPs) which in turninhibits the finaltranspeptidation stepof peptidoglycansynthesis in bacterialcell walls, thusinhibiting cell wallbiosynthesis. Bacteriaeventually lyse due toongoing activity of cellwall autolytic enzymes(autolysins and murein
hydrolases) while cellwall assembly isarrested.
1% to 10%:
Hematologic: Eosinophilia(7%), decreased hemoglobinand hematocrit (10%)
Hepatic: Increasedtransaminases (4%), increasedalkaline phosphatase (2%)
Local: Thrombophlebitis (1.7%)
8/4/2019 SCI Case Presentation Final
33/44
33
skin and soft tissue, bone andjoint, sepsis andgonorrhea
cephalosporins include toxicnephropathy, cholestasis,agranulocytosis, colitis,pancytopenia, aplastic anemia,hemolytic anemia, hemorrhage,prolonged PT, encephalopathy,asterixis, neuromuscularexcitability, serum-sicknessreactions, superinfection
Contraindication:
Hypersensitivity to cefuroxime,any component, orcephalosporins
potentially life-threatening complicationshould be ruled out asthe cause of diarrheaduring and afterantibiotic therapy.
Monitor formanifestations of hypersensitivity (seeAppendix F). Discontinuedrug and report theirappearance promptly.
Monitor I&O rates andpattern: Especiallyimportant in severely illpatients receiving highdoses. Report anysignificant changes.
8/4/2019 SCI Case Presentation Final
34/44
34
Tradename/Genericname
Classification/Indication Mechanism of action Adverse effect/Contraindication Nursing Interventions
Paracetamol Non-opioid analgesic
Indications:
Treatment of postoperativepain
Treatment of mild tomoderate pain and fever;does not have antirheumaticeffects (analgesic)
It isalso used to bringdown a hightemperature. Forthis reason,paracetamol can begiven to childrenafter vaccinationsto prevent post-immunizationpyrexia (hightemperature).
Inhibits the synthesisof prostaglandins inthe central nervoussystem andperipherally blockspain impulsegeneration; producesantipyresis frominhibition of hypothalamic heat-regulating center
Adverse effect:
Percentage unknown: Mayincrease chloride, bilirubin, uricacid, glucose, ammonia, alkalinephosphatase; may decreasesodium, bicarbonate, calcium
Contraindications:
Patients with known G-6-PDdeficiency; hypersensitivity toacetaminophen
Suppositories: Do not freeze
Suspension, oral: Shake
well before pouring a dose
Monitor for S&S of:
hepatotoxicity, evenwith moderateacetaminophen doses,especially inindividuals with poornutrition.
8/4/2019 SCI Case Presentation Final
35/44
35
Tradename/Genericname
Classification/Indication Mechanism of action Adverse effect/Contraindication Nursing Interventions
Terbutaline beta adrenergicreceptor agonists(stimulators)
Indications:Bronchodilator inreversible airwayobstruction andbronchial asthma
Relaxes bronchial smoothmuscle by action on beta 2-receptors with less effect on heart rate also inhibitsuterine activity.
Adverse effect:
>10%:
Central nervous system:Nervousness, restlessness
Neuromuscular & skeletal:Trembling
1% to 10%:
Cardiovascular: Tachycardia,hypertension
Central nervous system:Dizziness, drowsiness, headache,insomnia
Gastrointestinal: Xerostomia,nausea, vomiting, bad taste inmouth
Neuromuscular & skeletal: Musclecramps, weakness
Miscellaneous: Diaphoresis
8/4/2019 SCI Case Presentation Final
36/44
36
any component, cardiacarrhythmias associated withtachycardia, tachycardia causedby digitalis intoxication
Tradename/Genericname
Classification/Indication Mechanism of action Adversereaction/Contraindication
Nursing intervention
N -Acetylcysteine Classification: Mucolytic
Indications: Adjunctive mucolytic
therapy in patientswith abnormal orviscid mucoussecretions in acute andchronic
bronchopulmonarydiseases; pulmonarycomplications of surgery and cysticfibrosis; diagnosticbronchial studies;
antidote for acuteacetaminophen toxicity
Exerts mucolytic actionthrough its freesulfhydryl group whichopens up the disulfidebonds in themucoproteins thuslowering mucousviscosity. The exact mechanism of action in
acetaminophen toxicityis unknown; thought toact by providingsubstrate for conjugationwith the toxic metabolite
Adverse reaction:
>10%:
Gastrointestinal:Vomiting
Miscellaneous:Unpleasant odor during
administration
1% to 10%:
Central nervous system:Drowsiness, chills
Gastrointestinal:Stomatitis, nausea
Local: Irritation
Respiratory:Bronchospasm,rhinorrhea, hemoptysis
Miscellaneous:Clamminess
Assess patient fornausea, vomiting,and skin rash
8/4/2019 SCI Case Presentation Final
37/44
37
8/4/2019 SCI Case Presentation Final
38/44
38
name/Genericname
reaction/Contraindication intervention
Omeprazole Classification:proton pump inhibitors (PPI)
Indication:
Short-term treatment of activeduodenal ulcer
First-line therapy in treatment of heartburn or symptoms of GERD
Short-term treatment of activebenign gastric ulcer
GERD, severe erosiveesophagitis, poorly responsivesymptomatic GERD
Long-term therapy: Treatment of pathologic hypersecretoryconditions (Zollinger-Ellisonsyndrome, multiple adenomas,systemic mastocytosis)
Eradication of H. pylori withamoxicillin or metronidazole andclarithromycin
Prilosec OTC: Treatment of frequent heartburn (2 or more daysper week)
Unlabeled use: Posteriorlaryngitis; enhance efficacy of pancreatin for the treatment of steatorrhea in cystic fibrosis
Suppresses gastric acidsecretion by inhibitingthe parietal cell H+/K+ATP pump. By blockingthe production of acidis decreased, and thisallows the stomach andesophagus to heal.
Adverse reaction:
CNS: Headache,dizziness, asthenia,vertigo, insomnia,apathy, anxiety,paresthesias, dreamabnormalities
Dermatologic: Rash, inflammation,urticaria, pruritus,alopecia, dry skin
GI: Diarrhea,abdominal pain, nausea,vomiting, constipation,
dry mouth, tongueatrophy
Respiratory: URI symptoms, cough,epistaxis
Other: Cancer inpreclinical studies, back pain, fever
Contraindication
Known hypersensitivity toomeprazole
Capsuleshould beswallowedwhole; not chewed,crushed, oropened
8/4/2019 SCI Case Presentation Final
39/44
39
Trade name/Generic Classification/Indication Mechanism of action Adversei /C i di i
Nursing intervention
8/4/2019 SCI Case Presentation Final
40/44
40
name reaction/ContraindicationDopamine Classification:
Adrenergic Agonist Agent
Indication:
Increase cardiac output
Increase blood pressure
Increase urine flow
To correct hemodynamicimbalance in shock
syndrome due to MI(cardiogenic shock),trauma, endotoxicsepticemia (septic shock),open heart surgery, andCHF.
Stimulates bothadrenergic anddopaminergicreceptors, lowerdoses are mainlydopaminergicstimulating andproduce renal andmesentericvasodilation, higherdoses also are bothdopaminergic andbeta 1-adrenergicstimulating andproduce cardiacstimulation andrenal vasodilation;large doses stimulatealpha-adrenergicreceptors
Adverse reaction:
Cardiovascular:Ectopic beats,tachycardia, anginalpain, palpitations,hypotension,vasoconstriction
Central nervoussystem: Headache
Gastrointestinal:Nausea and vomiting
Respiratory: Dyspnea
Infrequent: Aberrant conduction,bradycardia,piloerection, widenedQRS complex,azotemia, elevatedpressure, polyuria,dilated pupils,ventriculararrhythmias (highdose), gangrene (highdose), hypertension,azotemia, anxiety,elevations in serumglucose (usually not
Extravasation: Due to short half-life, withdrawal of drug is often onlynecessarytreatment.
Use phentolamineas antidote; mix 5mg with 9 mL of NS; inject a smallamount of thisdilution intoextravasated area;blanching shouldreverseimmediately.
Monitor site; if blanching shouldrecur, additionalinjections of phentolamine maybe needed.
Monitor bloodpressure, pulse,peripheral pulses,and urinary output at intervalsprescribed by
physician. Precisemeasurements areessential foraccurate titrationof dosage.
Report the
8/4/2019 SCI Case Presentation Final
41/44
41
above normal limits);extravasation of dopamine can causetissue necrosis andsloughing of surrounding tissues.
Contraindication:
Hypersensitivity to sulfites(commercial preparationcontains sodium bisulfite);pheochromocytoma;ventricular fibrillation
followingindicators likereduced urine flowrate in absence of hypotension;ascendingtachycardia;dysrhythmias;disproportionaterise in diastolicpressure ,signs of peripheralischemia (pallor,cyanosis, mottling,coldness,complaints of tenderness, pain,numbness, or
burningsensation).
8/4/2019 SCI Case Presentation Final
42/44
42
Trade name/Genericname
Classification/Indication Mechanism of action Adversereaction/Contraindication
Nursing intervention
Lactulose Classification:Ammonia detoxicant,laxative
Indication: Adjunct in the
prevention andtreatment of portal-systemicencephalopathy(PSE) includinghepatic andprehepatic coma(Cephylac,Cholac, Enulose,
Evalose, Heptalacare used). treatment of
chronicconstipation
The bacterialdegradation of lactuloseresulting in an acidic pHinhibits the diffusion of NH3 into the blood bycausing the conversion of NH3 to NH 4+; alsoenhances the diffusion of NH3 from the blood intothe gut where conversionto NH 4+ occurs; producesan osmotic effect in thecolon with resultant distention promotingperistalsis
Adverse reaction:
>10%:Gastrointestinal:Flatulence,
diarrhea ,(excessive dose)
1% to 10%:Gastrointestinal:Abdominaldiscomfort,nausea, vomiting
Contraindication:
Patients withgalactosemia andrequire a low galactosediet, hypersensitivity toany component
Dilute lactulosein water, usually60-120 mL, priorto administeringthrough a gastricor feeding tube
Instruct the patient to:
Take sufficient liquid with eachdose and increasefluid intakeduring the day
Do not takeconcomitantlywith mineral oil
Do not take forprolongedperiods in lieu of proper dietarymanagement ortreatment andunderlyingcauses of constipation
8/4/2019 SCI Case Presentation Final
43/44
43
Trade name/Genericname
Classification/Indication Mechanism of action Adversereaction/Contraindication
Nursing intervention
Sulbactam-ampicillin Classification:Antibiotic, Penicillin
Indication:
Dental: Parenteralbeta-lactamase-resistant antibioticcombination to treat more severe orofacialinfections where beta-lactamase-producingstaphylococci and beta-lactamase-producingBacteroides are present
Medical: Treatment of susceptible bacterialinfections involvedwith skin and skinstructure, intra-abdominal infections,gynecological
infections; spectrum isthat of ampicillin plusorganisms producingbeta-lactamases suchas S. aureus , H.influenzae , E. coli,Klebsiella , Acinetobacter ,Enterobacter , and
The addition of sulbactam, a beta-lactamase inhibitor, toampicillin extends thespectrum of ampicillin toinclude some beta-lactamase producingorganisms; inhibitsbacterial cell wallsynthesis by binding toone or more of thepenicillin bindingproteins (PBPs); which inturn inhibits the final
transpeptidation step of peptidoglycan synthesisin bacterial cell walls,thus inhibiting cell wallbiosynthesis. Bacteriaeventually lyse due toongoing activity of cellwall autolytic enzymes(autolysins and mureinhydrolases) while cellwall assembly is
arrested.
Adverse reaction:
>10%: Local: Pain at
injection site (I.M.)1% to 10%:
Dermatologic: Rash
Gastrointestinal:Diarrhea
Local: Pain at injection
site (I.V.)
Miscellaneous: Allergicreaction (may includeserum sickness,urticaria,bronchospasm,hypotension, etc)
8/4/2019 SCI Case Presentation Final
44/44
44
anaerobes vomiting, enterocolitis,pseudomembranouscolitis, hairy tongue,dysuria, vaginitis,leukopenia,neutropenia,thrombocytopenia,
decreased hemoglobinand hematocrit,increased liverenzymes,thrombophlebitis,increasedBUN/creatinine,interstitial nephritis(rar
Contraindication:Hypersensitivity toampicillin, sulbactam orany component, orpenicillins
Type of I.V fluids Components of I.V fluid Class of I.V fluid Effect
Normal saline solution Sodium chloride, water, glucose isotonic mimics the bodiesnatural blood salt concentration andcontains 0.9% salt solution
prevent dehydration inpatients